Gast ::
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
In
The lancet 389(10084), Seiten/Artikel-Nr.:2117-2127
2017
Online
DOI: 10.1016/S0140-6736(17)30550-0
Einrichtungen
Thematische Einordnung (Klassifikation)
DDC: 610
Dokumenttyp
Journal Article
Format
online, print
Sprache
English
Anmerkung
Peer reviewed article
Externe Identnummern
WOS Core Collection: WOS:000401973300030
PubMed: pmid:28363480
SCOPUS: SCOPUS:2-s2.0-85016574686
Interne Identnummern
RWTH-2018-220790
Datensatz-ID: 715369
Beteiligte Länder
Belgium, Czech Republic, Denmark, Finland, Germany, Italy, Netherlands, Spain, Sweden, UK
; BIOSIS Previews ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; IF >= 40 ; JCR ; NCBI Molecular Biology Database ; Nationallizenz
; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Thomson Reuters Master Journal List ; Web of Science Core Collection
|
The record appears in these collections: |